Epsilon Healthcare (ASX:EPN) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

EPN Panoramica delle azioni

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.

EPN analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	2/6
Dividendi	0/6

Premi

Analisi del rischio

Gli utili sono diminuiti del 4.2% all'anno negli ultimi 5 anni

Non ha una capitalizzazione di mercato significativa ( A$7M )

Le azioni sono altamente illiquide

Ha meno di 1 anno di pista di cassa

+ 1 più rischio

Epsilon Healthcare Limited Concorrenti

Island Pharmaceuticals

ASX:ILA

AU$8.2m

Cann Global

ASX:CGB

AU$5.4m

Avecho Biotechnology

ASX:AVE

AU$9.5m

Nyrada

ASX:NYR

AU$10.0m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Epsilon Healthcare
Prezzi storici delle azioni
Prezzo attuale dell'azione	AU$0.024
Massimo di 52 settimane	AU$0.034
Minimo di 52 settimane	AU$0.016
Beta	0.92
1Variazione di 1 mese	0%
Variazione a 3 mesi	0%
Variazione di 1 anno	20.00%
3Variazione a 3 anni	-89.57%
Variazione a 5 anni	-95.60%
Variazione dall'IPO	-94.07%

Notizie e aggiornamenti recenti

Recent updates

Rendimenti per gli azionisti

	EPN	AU Pharmaceuticals	AU Mercato
7D	0%	0.9%	2.2%
1Y	20.0%	52.4%	11.2%

Ritorno vs Industria: EPN ha avuto una performance inferiore rispetto al Australian Pharmaceuticals che ha registrato un rendimento 50.6 % nell'ultimo anno.

Rendimento vs Mercato: EPN ha superato il mercato Australian che ha restituito 10.6 % nell'ultimo anno.

Volatilità dei prezzi

Is EPN's price volatile compared to industry and market?
EPN volatility
EPN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.1%
Market Average Movement	8.2%
10% most volatile stocks in AU Market	16.9%
10% least volatile stocks in AU Market	3.4%

Prezzo delle azioni stabile: EPN non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: Dati insufficienti per determinare la variazione della volatilità di EPN nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2016	n/a	Daniel Sanghera	epsilonhealthcare.com.au

Epsilon Healthcare Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Epsilon Healthcare con la sua capitalizzazione di mercato?
EPN statistiche fondamentali
Capitalizzazione di mercato	AU$7.21m
Guadagni(TTM)	-AU$5.93m
Ricavi(TTM)	AU$7.21m

1.0x

Rapporto P/S

-1.2x

Rapporto P/E

EPN è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
EPN Conto economico (TTM)
Ricavi	AU$7.21m
Costo del fatturato	AU$5.09m
Profitto lordo	AU$2.12m
Altre spese	AU$8.05m
Guadagni	-AU$5.93m

Ultimi guadagni dichiarati

Jun 30, 2023

Prossima data di guadagno

n/a

Utile per azione (EPS)	-0.02
Margine lordo	29.46%
Margine di profitto netto	-82.17%
Rapporto debito/patrimonio netto	27.1%

Come si è comportato EPN nel lungo periodo?

Vedi performance storica e confronto

EPN Panoramica delle azioni

Premi

Analisi del rischio

Epsilon Healthcare Limited Concorrenti

ASX:ILA

AU$8.2m

ASX:CGB

AU$5.4m

ASX:AVE

AU$9.5m

ASX:NYR

AU$10.0m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Recent updates

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Non-Executive Deputy Chairman recently bought AU$55k worth of stock

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

New minor risk - Share price stability

Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

Epsilon Healthcare Limited Announces Executive Changes

Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer

No independent directors

Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director

Epsilon Healthcare Limited Announces Board Changes

Epsilon Healthcare Limited Announces Resignation of Nicholas Marshall as Chief Financial Officer

Epsilon Healthcare Limited Announces Executive Changes

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

Epsilon Healthcare Limited Announces Resignation of Jarrod White as Chief Executive Officer

Epsilon Healthcare Limited Appoints Patrick Baiyu Xu as Director

Epsilon Healthcare Limited, Annual General Meeting, May 31, 2022

Epsilon Healthcare Limited announced that it expects to receive AUD 2.1 million in funding

No independent directors

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Epsilon Healthcare Limited announced that it expects to receive AUD 2.898 million in funding from CPS Capital

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Epsilon Healthcare Limited (ASX:EPN) entered into binding heads of agreement to acquire AlternaMed Pty Ltd. from Cannvalate PTY LTD for AUD 4.3 million.

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Joint Company Secretary Philip Leighfield has left the company

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Tetra Health Partners with Astrid Healthcare to Operates the Astrid Dispensary in South Yarra

Non Executive Director has left the company

Epsilon Healthcare Limited Announces Resignation of Gary Radcliff as Non-Executive Director

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Full year 2020 earnings released: AU$0.069 loss per share (vs AU$0.088 loss in FY 2019)

THC Global Group Limited announced that it expects to receive AUD 2.75 million in funding

New 90-day high: AU$0.29

THC Global Group Limited Announces CEO Changes

First half earnings released

New 90-day low - AU$0.24

New 90-day low - AU$0.26

THC Global Group Limited (ASX:THC) completed the acqusition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others.

New 90-day low - AU$0.27

THC Global Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.535 million.

Rendimenti per gli azionisti

Volatilità dei prezzi

Informazioni sull'azienda

Epsilon Healthcare Limited Riepilogo dei fondamenti

1.0x

-1.2x

Guadagni e ricavi